Salarius Pharmaceuticals Inc (SLRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 0 | 0 | 0 | 1,840 | 5,233 |
| Gross Profit | N/A | N/A | N/A | 1,840 | 5,233 |
| Operating Expenses | 5,734 | 12,895 | 31,841 | 14,653 | 13,020 |
| Operating Income | -5,734 | -12,895 | -31,841 | -12,813 | -7,786 |
| Other Income | 159 | 352 | 233 | 45 | 434 |
| Pre-tax Income | -5,576 | -12,543 | -31,608 | -12,768 | -7,352 |
| Net Income Continuous | -5,576 | -12,543 | -31,608 | -12,768 | -7,352 |
| Net Income | $-5,576 | $-12,543 | $-31,608 | $-12,768 | $-7,352 |
| EPS Basic Total Ops | -86.81 | -460.87 | -1,784.71 | -925.94 | -1,499.25 |
| EPS Basic Continuous Ops | -86.88 | -460.81 | -1,784.44 | -925.53 | -1,415.13 |
| EPS Diluted Total Ops | -86.81 | -460.87 | -1,784.71 | -925.94 | -1,499.25 |
| EPS Diluted Continuous Ops | -86.88 | -460.81 | -1,784.44 | -925.53 | -1,415.13 |
| EPS Diluted Before Non-Recurring Items | -86.81 | -460.57 | -1,284.56 | -929.54 | -1,499.25 |
| EBITDA(a) | $-5,730 | $-12,885 | $-31,835 | $-12,794 | $-7,768 |